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This study aimed to verify the adherence, knowledge and the difficulties of elderly patients with 
Bipolar Affective Disorder (BAD) in relation to the prescribed pharmacological therapy for the 
control of this disorder. The study included 17 elderly patients with BAD treated at a Mental Health 
Center. Semi-structured interviews were conducted and scales were applied. The data were 
analyzed using a quali-quantitative approach. A low level of adherence to the pharmacological 
treatment and a deficit in knowledge in relation to the medication were identified, especially 
regarding the dose and frequency of administration. Among the difficulties inherent to the 
pharmacotherapy, the obligation of polypharmacotherapy, the desire to quit the pharmacological 
treatment, limitations in the self-administration of the medication, collateral effects, and doubts 
about the need for the medication were related. Investment is needed in educational activities 
and in the promotion of adherence that address the difficulties experienced by elderly people 
with BAD in the following of the pharmacotherapy in order to ensure safety in the medication 
therapy.
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Terapêutica medicamentosa: adesão, conhecimento e dificuldades de 
idosos com transtorno bipolar
Este estudo teve como objetivo verificar a adesão, o conhecimento e as dificuldades de 
idosos com transtorno afetivo bipolar (TAB), em relação à terapêutica medicamentosa, 
prescrita para controle do referido transtorno. Participaram do estudo 17 idosos com TAB 
atendidos em um núcleo de saúde mental. Foram realizadas entrevista semiestruturada 
e aplicação de escalas. Os dados foram analisados com abordagem quali-quantitativa. 
Identificou-se baixo grau de adesão ao tratamento farmacológico e déficit no conhecimento 
sobre os medicamentos, especialmente sobre as doses e frequência de administração. 
Entre as dificuldades inerentes à farmacoterapia relataram-se: a obrigatoriedade da 
polifarmacoterapia, o desejo de encerrar o tratamento farmacológico, limitações na 
autoadministração dos fármacos, efeitos colaterais e dúvidas sobre a necessidade dos 
medicamentos. São necessários investimentos em ações educativas e de promoção da 
adesão que contemplem as dificuldades vivenciadas pelos idosos com TAB, no seguimento 
da farmacoterapia, para garantia de segurança na terapêutica medicamentosa.
Descritores: Transtorno Bipolar; Adesão à Medicação; Idoso.
Terapéutica medicamentosa: adhesión, conocimiento y dificultades de 
personas ancianas portadoras de trastorno bipolar
Este estudio tuvo como objetivo verificar la adhesión, el conocimiento y las dificultades 
de ancianos con Trastorno Afectivo Bipolar (TAB) en relación a la terapéutica 
medicamentosa prescrita para control del referido trastorno. Participaron del estudio 17 
ancianos con TAB atendidos en un Núcleo de Salud Mental. Fueron realizadas entrevistas 
semiestructuradas y aplicación de escalas. Los datos fueron analizados con abordaje 
cualitativo-cuantitativo. Se identificó bajo grado de adhesión al tratamiento farmacológico 
y déficit en el conocimiento sobre los medicamentos, especialmente sobre las dosis y 
frecuencia de administración. Entre las dificultades inherentes a la fármacoterapia fueron 
relatadas la obligatoriedad de la polifármacoterapia, el deseo de terminar el tratamiento 
farmacológico, las limitaciones en la auto-administración de los fármacos, los efectos 
colaterales y las dudas sobre la necesidad de los medicamentos. Se concluye que son 
necesarias inversiones en acciones educativas y de promoción de la adhesión que 
contemplen las dificultades experimentadas por los ancianos con TAB en el seguimiento 
de la fármacoterapia para garantizar la seguridad en la terapéutica medicamentosa.
Descriptores: Trastorno Bipolar; Cumplimiento de la Medicación; Anciano.
Introduction
Brazil is going through an accelerated aging 
process of the Brazilian society. In 2006, there were 
approximately 19 million individuals over 60 years of 
age(1). A consequence of the aging of the population is 
an increase in the prevalence of chronic conditions and 
a high consumption of medication(2-3). Bipolar Affective 
Disorder (BAD) in the elderly is a growing public health 
problem(4). However, there is a lack of epidemiological 
studies on the disorder in this age group(5). It is known 
that in the United States, the prevalence rates of BAD 
in the elderly vary between 0.1% and 0.4%. However, 
this disorder affects around 10% to 25% of all elderly 
patients with mood disorders and is responsible for 
5% of the hospitalizations of elderly due to psychiatric 
causes in the country(6). In Brazil, there is no accurate 
information on the incidence and prevalence of BAD in 
the elderly. However, the diagnosis of BAD in the elderly 
is highlighted as a cause of psychiatric hospitalizations 
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in this group(5). Drug treatment is essential for the 
control of BAD in all its stages and in all ages(6). 
However, the success of pharmacotherapy is conditional 
on the adherence to medication treatment and there are 
several factors that act as barriers to the adherence of 
the person with BAD to the medication. Among these 
barriers, may be the lack of knowledge regarding the 
prescribed medication(7).
Research conducted in 2007 in the same service 
in which the present study was performed investigated 
the adherence to treatment and the satisfaction with 
the healthcare team and pharmacotherapy in adults 
with BAD. The study found that although most patients 
claimed satisfaction with the effectiveness of the 
medication and with the information received in the 
health service, only 28.5% of the patients adhered to 
the pharmacological treatment(8). However, there are 
no studies that evaluate the medication adherence 
and the knowledge regarding the medication of the 
contingent of elderly people with BAD. It is a fact that 
elderly patients with BAD often have specific needs 
related to treatment compared with young individuals. 
These requirements are due to factors typical of old 
age: physical comorbidities (especially chronic diseases) 
social isolation, cognitive alterations, limitations in 
performing activities of daily living, polypharmacy, and 
age-related variations in the response to therapy, among 
others(2,6). It can be verified, in the literature, that the 
specifics of the management of the pharmacological 
treatment of BAD geriatrics have been little studied in 
comparison with management in the young population. 
An advance in the development of scientific knowledge 
regarding BAD geriatrics and their treatment could 
provide an improvement in the care to this group(4-6,9). 
The entire context described points to the importance of 
research on the adherence to pharmacotherapy, as well 
as the knowledge and difficulties of elderly patients with 
BAD related to prescription medication, with the aim of 
providing subsidies for the optimization of the treatment 
offered to this clientele.
Aims
This study aimed to determine the degree of 
adherence, the level of knowledge and the difficulties of 
elderly people with BAD related to the following of the 
prescribed pharmacological therapy.
Methodology
This is a cross-sectional, descriptive, quail-
quantitative study. It was held in the domiciles of elderly 
people with BAD treated at a mental health center (MHC), 
of a municipality in the interior of São Paulo State, which 
is part of the Brazilian National Health System (SUS). 
The project was developed after its approval by the 
Research Ethics Committee of the institution (Protocol 
No.269/CEP-CSE-FMRP-USP). All patients aged 60 
or older, diagnosed with BAD, with continuous use of 
medication for treatment of this disorder and who had 
consultations scheduled with the physicians of the MHC 
within the period of three months after the start of data 
collection, were selected for the study. Further inclusion 
criteria adopted were: to be able to communicate 
verbally, to agree to participate in the study and to 
sign the terms of informed consent. The Mini Mental 
State Examination (Mini-Mental)(10) was applied, using, 
according to this examination, a score of less than 24 for 
educated subjects and scores below 18 for the illiterate 
as criteria for exclusion from the study(11).
For the data collection a semi-structured 
interview was used, guided by a script prepared by the 
authors of the study, which consisted of data on the 
characterization of the subjects, questions related to 
adherence and to the knowledge of the elderly about the 
instituted pharmacotherapy, and data referring to the 
difficulties of the participants in relation to following the 
pharmacological treatment. The data were analyzed using 
a quali-quantitative approach. The degree of adherence 
was defined by applying the Morisky-Green test(12). 
This test identifies the degree of patient adherence and 
discriminates as to whether the possible non-adherence 
is due to intentional behavior (questions: “When you 
feel well, do you ever stop taking your medication?” and 
“when you don’t feel well, even with the medication, 
do you stop taking it sometimes?”) or unintentional 
behavior (questions: “have you ever forgotten to take 
your medicine?” and “are you sometimes careless 
about the time to take your medicine?”). The test was 
validated in other studies and has been translated and 
applied in Brazil(13-15). The responses were assigned a 
value of 0 (zero) or 1, with the value 1 given for each 
positive response in which the admitted frequency was 
of once per month or less, and the value 0 (zero) for 
other possibilities of frequency. The criterion adopted 
to classify the degree of adherence was: “adherent” 
the patients who obtained four points in Morisky-Green 
test(12) and “non-adherent” those who obtained 0 to 3 
points.
To categorize the degree of knowledge of the 
patients regarding prescribed medication, a scale was 
adopted already employed in previous studies(16-17). In 
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this scale, the degree of knowledge can be categorized 
from 0 to 100% in five intervals representing the 
following classes: “without knowledge” (0%) “very 
little knowledge” (0%  25%), “little knowledge” (25% 
 50%); “average knowledge” (50%  75%) and “good 
knowledge” (75%  100%). This scale was used to 
categorize the degree of patient knowledge regarding 
the following aspects of the medication: name, dose 
and frequency of use. The answer to each question 
was classified as right or wrong, considering each 
medication prescribed for the patient. The answer “do 
not know” was classified as wrong. Thus, when there 
were 10 medications prescribed for a patient, if the 
patient was able to correctly report the names of four of 
them, the degree of knowledge of the patient would be 
40% and they would be included in the category “little 
knowledge” in relation to the names of the medication. 
Proceeding in this way for the other variables related to 
the medication.
The data related to the characterization of 
study participants and to their knowledge about the 
pharmacological therapy were entered into a structured 
database in spreadsheet format, using the Excel program 
and subsequently transported to the Statistical Package 
for the Social Sciences (SPSS version11.5). For analysis 
of the data concerning the difficulties of the patients in 
following the pharmacotherapy, a qualitative approach 
was used, based on the steps proposed by Minayo(18): 
sorting of the collected data, classification of the data 
(development of the central empirical categories) and 
the final analysis (articulation of the empirical data with 
the literature).
Results
Categorization of the study subjects
Within three months of the start of the study, 17 
elderly people with BAD who fulfilled the study inclusion 
criteria had scheduled medical consultations in the 
mental health center. Of these 17 patients interviewed, 
it was verified that the majority were female (76.47%), 
married (52.94%), retired due to the disorder (70.58%) 
and had incomplete elementary education (58.82%). 
Regarding the medications used by the study subjects 
for the control of psychiatric symptoms, it was found that 
15 patients (88.24%) were using mood stabilizers and 
that antipsychotics were prescribed for seven (41.18%) 
interviewees. It is also noteworthy that five (29.41%) 
were taking benzodiazepines and three (17.65%) 
individuals were using antidepressants.
Behavior related to adherence to the pharmacological 
treatment
Adherence to the pharmacological treatment 
was assessed using the Morisky-Green test(12) which 
allows the evaluation of whether the possible non-
adherence is due to intentional behavior (stop taking 
the medication because they feel well or feel bad) or 
unintentional (forgetfulness and carelessness regarding 
the time of medication). Among those investigated, only 
two patients (11.76%) were identified that adhered to 
the prescribed pharmacological treatment. Of the total 
interviewees, 11 (64.72%) were non-adherent through 
unintentional behavior, while two (11.76%) were non-
adherent through intentional behavior. It was verified 
that two (11.76%) study participants were not adhering 
to the prescribed medication due to both intentional and 
unintentional behavior.
The degree of knowledge about the medication
This study evaluated the degree of patient 
knowledge regarding the medication prescribed by the 
psychiatrist, comparing the last medical prescription 
available in the patient’s records, with the medications 
referred to by the patient. The degree of knowledge was 
analyzed regarding the name, dose and frequency of the 
medications, as shown in Figure 1.
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Figure 1 - Distribution of the study subjects according 
to the degree of knowledge of dosage, frequency and 
name of the medication
It was observed that the lowest degree of knowledge 
was related to the dose and frequency of medication 
administration. In both of the variables, the majority 
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of interviewees (58.82%) presented 0% knowledge. 
Regarding the dose, the responses considered correct 
were those that identified the quantity, in units of 
measurement (grams, milligrams and milliliters), to be 
administered at each time or within 24 hours, according 
to the medical prescription. Figure 1 shows that only 
five (29.41%) patients were able to report more than 
75% of the names of the medications in use. To evaluate 
their knowledge about the names of the medications the 
answer accepted as correct was one that identified the 
medication prescribed by either the generic name or by 
any commercial name.
The difficulties related to the pharmacological therapy 
for elderly people with BAD
From the content analysis of the interviews some 
categories emerged that described the difficulties in 
following the prescribed pharmacological treatment of 
elderly people with BAD, as described below.
Needing to tolerate polypharmacotherapy
This category describes the patient inserted 
on a trajectory of use of various types of medication 
in an attempt to stabilize the mood and control co-
morbidities. In addition to the psychotropic drugs 
prescribed to control the BAD, the elderly often need 
to continually use medication to control co-morbidities 
such as hypertension and diabetes, among others. In 
this context, the individual depreciates the fact of taking 
“too much medicine”, as indicated by the reports below.
For high pressure I use Captopril, I have one that is for 
cholesterol that I cannot remember the name of, it is a small 
red pill... but I take Metformin because I have diabetes, I take 
Arzocon, also for diabetes, I take ASS ... I take the mental health 
medicine... Carbolitio, I take Chlorpromazine and Akineton... 
and I take Cloran in the morning. (S1)
I use Fluoxetine, Cortisone Acetate... I take vitamin B3, 
Calcium carbonate, Meprozol... it is a lot of medicine I take 
that for high pressure, Sodium Carbonate, Simvastatin one per 
night... Omeprazole ... Hydrochlorothiazide... I think it’s too 
much medicine, I think to myself that it is too much medicine, 
so I don’t see it. (S8)
It is a lot of medicine... Then I get confused... (S6)
It is worth noting that the need to use many drugs 
simultaneously is considered a “confusing” factor for the 
patient, impairing their independence to self-administer 
the prescribed medication.
Having limitations for the self-administration of the 
prescribed medication
It was identified that the difficulty of ingesting 
medication on time and in the correct dosage becomes 
pronounced in the elderly. This aspect is clearly identified 
in the statements of the interviewees, where forgetting 
is cited as an ordinary and relatively frequent event.
I would say that I forget about four times a month... (S7)
Forget, I forget a lot... About three times (per week)... 
(S16)
It was perceived that faced with the difficulties in 
administration of the medication, the elderly with BAD 
adopt various strategies to not forget when to do this, as 
revealed in the following reports.
When I go to lunch I put it here (points to table)... To not 
forget... And at two o’clock I take it, if I lie down a bit I set the 
alarm and to get up and take it. (S3)
I have a small bag of medicine. So I put everything there 
in sequence, then take the first, put it in the bag, the second, 
put it in the bag, otherwise I get confused, I do not know if I 
took it or if I did not take it, understand? (S4)
My medicine, it is all written down, the envelope of my 
medication was made with: the moon, the sun, so that I don’t 
mix them, to not get confused with the medicine. The girl here 
who taught me, she makes the envelope. (S16)
When help is needed for the administration of their 
medication, there are elderly with BAD who have family 
support to make sure the therapy is followed correctly.
I do not take alone. My wife gives me (medication). I do 
not remember any. (S2)
They (family members) are quite on top of me... all the time 
asking if I am feeling better, taking the medicines correctly... 
they put the medicines near the TV so I will not forget to take. 
(S13)
However, not all the elderly people find the support 
they need for the pharmacological treatment to be 
adequately followed. The statements below highlight 
this issue.
They never put the pill in my hand, I can arrive at the 
hospital weak, never, never, never. (S3)
They do not help me, no my dear! There are things that I 
do not even like to talk about! So, we have to be very tolerant, 
right? (S8)
They do not help much... They are not accustomed to 
remembering their things much, so I take care of myself mostly. 
(S11)
Needing to adhere, but wishing to not adhere to 
pharmacotherapy
When living with a chronic disease that requires 
the prolonged use of a medication, the desire and hope 
to one day be able to terminate the pharmacological 
treatment was identified among the subjects.
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The other one (physician) said I’ll have to take Carbolitio 
for my entire life, I said God willing I’ll stop one day... I will ... 
but for now I cannot. (S5)
I say ‘I do not think I need it anymore’, you know? Because 
I take too much medicine... I feel like stopping the Haldol ... 
(S6)
The desire to quit using medication to control the 
disorder may be related to non-adherence. There were 
reports that highlighted how some patients experiment 
by interrupting the use of the medication.
I thought I was well, so I stopped taking the Carbolitio... I 
tried to stop, thinking that I was cured ... I think I stopped about 
three times because I thought I was good and I was reducing the 
medication on my own. (S4)
I stopped taking the medicine because I thought it was not 
doing anything... I already tried, you know? There was a time 
that I tried... to see if I could stay without taking the medicine, 
but I could not. (S9)
The statements reveal that attempting to stop 
the medication causes crises, the patients are afraid to 
initiate further attempt to discontinue the use of it.
I got a little angry that I had to take medicine, I said that 
I was not crazy, and then I said I did not need to take it at all... 
The days I stopped taking the medicine, I was screaming, I was 
desperate... Then I saw for myself that I could not go without 
the medicine. (S14)
I know it will give me problems if I don’t take... I get much 
worse if I don’t take... I’m worse without them, if I stop taking 
them, then I become crazy because of the illness. (S7)
I knew I was not going to improve if I did not take it, right? 
Then I said: “No... I cannot do this to myself...” so I started 
taking it again. (S12)
Having collateral effects
The prolonged use of medication causes, as a 
consequence, the emergence of collateral effects. The 
reports of the patients evidenced the presence of such 
effects, causing discomfort and restricting their quotidian 
activities. There were complaints of drowsiness, 
dizziness, stomach discomfort, dermatitis, tremors, 
weight gain and decreased libido.
I feel a great drowsiness, I sleep about 13 to 14 hours a 
day... and the sexual part too. I have been gradually reducing (the 
medication) and now it’s really bad! This worries me more. (S7)
It bothers me... the tremors in the hands, because 
sometimes I’ll go to read a paper and... it bothers me. (S5)
Getting fat... To get fat is not good, because we already 
have the problem that is chronic. (S1)
It gave me a skin allergy, made my skin all spotty, the 
Carbamazepine… (S8)
I had difficulties because of the pain in my stomach... and 
I complain all the time. (S10)
It was verified, through the reports, that although 
the elderly patients recognized the necessity for the 
medication to control the BAD, the fear of its collateral 
effects is constant. The following statement expresses 
the desire of the elderly patients to use an alternative 
form of treatment (medicine) to psychotropic drugs.
It is ... it’s bad for other things, but, what can you do? 
But at least the mind works, right?... It (the medicine) is very 
chemical then I talked to the Dr. I wanted to take another 
medicine that was less chemical. (S4)
Questioning the need for the medication
There were patients who did not have much 
information about the disorder so they questioned the 
necessity of prescribed pharmacological treatment. Their 
statements also revealed the desire to obtain information 
about the disorder and the medication in use.
I don’t know why I have to be taking this (medication)... I 
did not want to accept at all that I had to be taking it... I had to 
leave a life that was normal. (S12)
I know that I have to take the medicine, but sometimes I 
don’t know what for... I take the medicine to try to be well, right? 
But I do not know if I will be well with this medicine. (S15)
Until today I do not know what this disease is. However, 
I suffer more... Oh, I wish the person would tell me what this 
disease means. (S16)
It was verified among the study subjects that, when 
they perceive themselves using a lot of medication, 
presenting collateral effects from it, and not having 
immediate results, they begin to question the efficacy 
of the pharmacological treatment. Their statements 
also reveal that despite not perceiving improvement in 
the symptomology, “you must accept” the medication 
because “the doctor says so”, expressing their total 
belief in the medical truth, becoming passive to the will 
of the physician.
If I take medicine for a headache, I feel better... with the 
Carbolithium I do not feel anything, if it improves, if it does not 
improve, I have to accept what the doctor says, right? But do I 
feel an improvement in my body? No, I feel nothing. (S5)
There are days when I say “I’m taking this medicine for 
nothing, just filling myself with medicine”, it’s not resolving 
anything. (S6)
Discussion
This study identified the degree of adherence to 
the pharmacological treatment, the level of knowledge 
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and the difficulties of 17 elderly patients with BAD in 
relation to the pharmacotherapy prescribed. It was 
found that the majority (76.47%) of the participants 
were female. Although, in the literature there is no 
significant difference in the prevalence of BAD between 
the genders, the higher number of women attended 
in the MHC could be due to the significantly lower 
tendency of men with BAD to seek medical attention 
when compared to women(19).
The medication most commonly used by the 
study subjects for the control of psychiatric symptoms 
were mood stabilizers, followed by antipsychotics, 
benzodiazepines and antidepressants. These findings 
are corroborated by the literature which shows that 
currently BAD treatment in the elderly includes mood 
stabilizers (lithium, anticonvulsants) which, in some 
cases may be associated with antipsychotics, anxiolytics, 
antidepressants and electroconvulsive therapy(6,20).
This study identified a high rate of non-adherence 
to the pharmacological treatment among the elderly 
patients with BAD. In this respect, the international 
literature shows that approximately 50% of bipolar 
patients interrupt the treatment at least once, while 
30% of them do so at least twice(21). It is noteworthy that 
non-adherence to medication significantly undermines 
the efficacy of it and is associated with poor prognosis, 
increased risk of relapse and suicide, and greater 
consumption of health system resources(22).
Low levels of patient knowledge, regarding 
the prescribed medication, were identified, and the 
knowledge deficit was higher in relation to the dose and 
frequency of administration of the medication. The lack 
of knowledge in this regard can cause both omissions of 
doses as well as extradoses. Thus, these elderly patients 
can be exposed to ineffective treatment through the use 
of pharmaceuticals below the therapeutic levels and the 
risk of toxicity due to the maintenance of medication 
above therapeutic doses, with such risks being 
exacerbated by the peculiarities of the metabolism of 
medication in the elderly(6).
This study found that only five patients were able to 
relate more than 75% of the names of the medications 
in use. Knowing the name of the medication is essential 
so that the patient knows how to differentiate it at the 
time of purchase and use, as well as being able to give 
information about them on the occasion of hospital 
admissions, examinations, adverse reactions and 
allergies, among others.
It is emphasized that knowledge regarding the 
name, dose and frequency of medication administration 
is of paramount importance for the patient to be able to 
avoid mistakes in their usage. The deficit of knowledge 
regarding this can indicate, among other aspects, a 
failure or deficiency in the process of patient education 
by health professionals.
The simultaneous use of multiple pharmaceuticals 
was one of the problems experienced in the following 
of the pharmacological therapy. According to the survey 
participants, the polypharmacotherapy may increase 
the difficulties for self-administration of the prescribed 
medications, raising the possibility of non-adherence. 
The use of many medications can also increase the 
likelihood of the occurrence of collateral effects.
The literature suggests that polypharmacy is a 
significant problem in old age that requires special 
attention from health professionals(3). A study(23) revealed 
that the majority of elderly people consume at least 
one medication and around one third of them consume 
five or more simultaneously, corroborating the findings 
of this study. The limitation of ingesting medication 
at the correct time and dosage becomes pronounced 
in the elderly, especially due to forgetting the time of 
administration. This difficulty in remembering the time 
of medication administration constitutes a risk of non-
adherence due to non-intentional behavior, which was 
identified in 64.72% of the participants of this study. 
This aspect may be related, among other thing, to the 
polypharmacotherapy, to the disorder and to the age 
range studied, because elderly patients with BAD tend to 
present cognitive impairments hindering the recognition 
and retention of the medication administration 
schedules(23-24). For the elderly people with BAD who 
have limitations for the self-administration of medication 
it is crucial to involve the family in the provision of help. 
Family members of elderly outpatients with BAD are in 
a unique position to identify problems and to intervene 
collaborating in the treatment. To do so, it is necessary 
that they are assisted, prepared and supported by the 
health professionals(25).
It was found that the elderly patients with BAD had 
a desire to interrupt the pharmacotherapy, with some 
experimenting with discontinuing the use of medication 
to test the real necessity for it. In this respect, there 
are authors who mention that this kind of testing, that 
some more active patients, especially chronic patients, 
develop with their treatment, is justified by the intention 
to overcome the stigma of chronic disease as well as to 
mitigate certain interference in their quotidian caused 
by the rigid following of the medication prescriptions and 
their collateral effects(21,26).
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It was perceived that when the attempt to interrupt 
the pharmacological treatment caused crises, the 
patients understood the need for the medication. It was 
noted that at this moment adherence is seen as the 
only path available to achieve emotional stability and, 
thus, the patient feels compelled to take the medication. 
The limitations and discomfort caused by the collateral 
effects of the medication are a constant in the quotidian 
of the elderly patients with BAD. The literature reveals 
that the collateral effects of the medication significantly 
impair the quality of life of the patients and may be the 
main obstacle for the adherence to the pharmacological 
treatment(27).
The lack of information regarding the disorder 
and lack of immediate results in the pharmacological 
treatment were related to doubts about the necessity and 
efficacy of the prescribed pharmacological treatment. 
These findings highlight the need for a greater investment 
in the education of the patients and family members in 
relation to the disorder and treatment.
In the following of the pharmacological therapy, the 
study participants faced a variety of difficulties which 
were closely interrelated and mutually reinforcing. 
The categories constructed in this study regarding the 
difficulties presented by the elderly patients with BAD 
may indicate problems that deserve to be investigated 
by the professionals who work in mental health.
Final considerations
This study verified the degree of adhesion, the level 
of knowledge and the difficulties associated with the 
pharmacological treatment in 17 elderly patients with 
BAD. A low level of adherence to the pharmacological 
therapy was identified in this population, which indicates 
a poor prognosis for the disorder in this clientele. It was 
found that there was a lack of knowledge, especially 
regarding the doses and frequency of the medication. 
This limitation indicates that these elderly patients 
may be exposed to important risks in the following of 
the pharmacological therapy, especially when using 
medication with a narrow therapeutic range. This finding 
also indicates the need for supervision of the elderly 
with BAD in the self-administration of the prescribed 
medication, the presence of a family member/caregiver 
being relevant. In this context, an important strategy 
to introduce the family member/caregiver into the 
care for the elderly in medication therapy consists of 
the organization, in the health institutions, of groups of 
family members for health education, coordinated by 
the professionals.
Educational actions involving elderly people with 
BAD are also very important, because the promotion of 
adherence to the treatment and a better understanding 
of this are aspects considered essential for safety 
in pharmacological therapy. Many difficulties in the 
following of the medication therapy were raised, which 
may contribute to the lack of medication adherence in 
the clientele of the study: the polypharmacotherapy, 
the collateral effects, the limitations for the self-
administration of the prescribed medication, the lack of 
information about the disorder and treatment, the belief 
that the medication is ineffective, and the desire to 
interrupt the pharmacological treatment. Such problems 
deserve to be investigated by the professionals in the 
clinical practice so that interventions can be established 
that can minimize the consequences of the treatment.
By caring for elderly patients with BAD, it is 
essential to know the limitations, motivations and 
barriers that they may face in the following of the 
pharmacological therapy. Merely having this knowledge, 
the health professional may propose actions that impact 
on the reality of the client. The results of this study also 
highlight the need to implement strategies that motivate 
the patients to adhere to the pharmacological therapy, 
assuming greater responsibility and active participation 
in the treatment instituted.
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